Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. Although the ...
Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...
Precigen (PGEN) reported better-than-expected first-quarter earnings and is making strides toward commercializing its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback